Corfas G

No ORCID on file · 1 paper in corpus · active 2008
2008
Nature biotechnology ·doi:10.1038/nbt1415

Targeting angiogenesis, the formation of blood vessels, is an important modality for cancer therapy. TNP-470, a fumagillin analog, is among the most potent and broad-spectrum angiogenesis inhibitors. However, a major clinical limitation is …